Currently Viewing:
The American Journal of Managed Care May 2012
Economic Benefits of BIS-Aided Assessment of Post-BC Lymphedema in the United States
Sara P. Bilir, MS; Mitchell P. DeKoven, MHSA; and Juliet Munakata, MS
CAH Staff Perceptions of a Clinical Information System Implementation
Marcia M. Ward, PhD; Smruti Vartak, PhD; Jean L. Loes, RN, BSN, MS; John O'Brien, MBA; Troy R. Mills, MS; Jonathon R. B. Halbesleben, PhD; and Douglas S. Wakefield, PhD
Impact of Certified CME in Atrial Fibrillation on Administrative Claims
Stephanie A. Stowell, MPhil; Allison J. Gardner, PhD; Joseph S. Alpert, MD; Gerald V. Naccarelli, MD; Thomas P. Harkins, MA, MPH; Anthony M. Louder, PhD, RPh; and Leonardo Tamariz, MD, MPH
Currently Reading
Medication Adherence Changes Following Value-Based Insurance Design
Joel F. Farley, PhD; Daryl Wansink, PhD; Jennifer H. Lindquist, MStat; John C. Parker, PhD; and Matthew L. Maciejewski, PhD
Guideline-Based Peer-to-Peer Consultation Optimizes Pegfilgrastim Use With No Adverse Clinical Consequences
Marc L. Fishman, MD; Akhil Kumar, MD; Sharon Davis, MPH; William Shimp, MD; and William J. M. Hrushesky, MD, FACP
Infused Chemotherapy Use in the Elderly After Patent Expiration
Rena M. Conti, PhD; Meredith B. Rosenthal, PhD; Blase N. Polite, MD; Peter B. Bach, MD, MAPP; and Ya-Chen Tina Shih, PhD
Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch Syndrome
Grace Wang, PhD, MPH; Miriam Kuppermann, PhD, MPH; Benjamin Kim, MD, PhD; Kathryn A. Phillips, PhD; and Uri Ladabaum, MD, MS
Impact of Payment Reform on Chemotherapy at the End of Life
Carrie H. Colla, PhD; Nancy E. Morden, MD, MPH; Jonathan S. Skinner, PhD; J. Russell Hoverman, MD, PhD; and Ellen Meara, PhD
Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer
Joseph C. Hodges, MD, MBA; Yair Lotan, MD; Thomas P. Boike, MD; Rhonda Benton, BS, CMC; Alyson Barrier, BBA; and Robert D. Timmerman, MD
Implementation of Cancer Clinical Care Pathways: A Successful Model of Collaboration Between Payers and Providers
Bruce A. Feinberg, DO; James Lang, PharmD, MBA; James Grzegorczyk, MS, RPh; Donna Stark, RPh, MBA; Thomas Rybarczyk, RN, BSN; Thomas Leyden, MBA; Joseph Cooper; Thomas Ruane, MD; Scott Milligan, PhD; Philip Stella, MD; and Jeffrey A. Scott, MD

Medication Adherence Changes Following Value-Based Insurance Design

Joel F. Farley, PhD; Daryl Wansink, PhD; Jennifer H. Lindquist, MStat; John C. Parker, PhD; and Matthew L. Maciejewski, PhD
Value-based insurance design copayment reductions sustained medication adherence 2 years into policy implementation and were most effective in patients with poor adherence before policy implementation.
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up